Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Mounjaro/Zepbound (tirzepatide), approved dual GLP-1/GIP agonist for type 2 diabetes and obesity Recent Highlights: In April 2026, the FDA approved orforglipron (Foundayo), making it one of the first oral GLP-1 pills that can be taken any time of day and that has no food or water restrictions
Obstructive sleep apnea syndrome and autonomic dysfunction
GLP-1 Users Will Spend 2x More Than Non-Users On Clothes This Black Friday On Black Friday, GLP-1 users plan to spend an average of $350 on clothing, compared to $150 for non-GLP-1 users
Close monitoring by a healthcare provider is recommended to ensure the medication's efficacy and safety
That matters because a real worry has circulated among patients with Crohn's disease and ulcerative colitis: that a drug which slows gastric emptying and commonly causes nausea, diarrhea and constipation might aggravate an inflamed bowel or mask a flare
Overview of biologics Biologics are a class of therapeutic agents derived from biological sources, including proteins, nucleic acids, and living cells
US$ 24.13
US$ 20.64
US$ 21.51
US$ 23.64
